Spots Global Cancer Trial Database for Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma
Official Title: Multicenter, Prospective, Open Label Trial, Uncontrolled to Determine the Efficacy and Safety of Depocyt ® for the Treatment of CNS Relapse in Adult Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma
Study ID: NCT00388531
Interventions
Study Description
Brief Summary: The first purpose is to confirm or not the efficacy of only one administration of DepoCyte®.
Detailed Description: It is a clinical study multicenter, prospective, open label trial, uncontrolled and nonrandomized
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hospital "Santa Creu i Sant Pau", Barcelona, , Spain
Hospital Clínico y Provincial de Barcelona, Barcelona, , Spain
Hospital Germans Trias i Pujol, Barcelona, , Spain
Hospital Clínico San Carlos de Madrid, Madrid, , Spain
Hospital Doce de Octubre, Madrid, , Spain
. Hospital Clínico Universitario Virgen de la Victoria, Málaga, , Spain
Hospital Clínico Universitario de Salamanca, Salamanca, , Spain
Hospital Universitario Virgen del Rocío, Sevilla, , Spain
Hospital La Fe, Valencia, , Spain
Contact Details
Name: Josep Mª Ribera, Doctor
Affiliation: Germans Trias i Pujol Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
